Description
Schizophrenia Related Peptide (Highly Pure)
| Catalog number: | B2012653 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 500 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Synthetic Peptides |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Upthegrove R, Khandaker GM. Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia Curr Top Behav Neurosci. 2020;44:49-66.
- Na KS, Jung HY, Kim YK. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:277-86.
- Di Carlo P, Punzi G, Ursini G. Brain-derived neurotrophic factor and schizophrenia Psychiatr Genet. 2019 Oct;29(5):200-210.
- Lpez A, Mendieta L, Prades R, Royo S, Tarrag T, Giralt E. Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia Future Med Chem. 2013 Sep;5(13):1509-23.
- Xuan FL, Yan L, Li Y, Fan F, Deng H, Gou M, Chithanathan K, Heinla I, Yuan L, Seppa K, Zharkovsky A, Kalda A, Hong LE, Hu GF, Tan Y, Tian L. Glial receptor PLXNB2 regulates schizophrenia-related stress perception via the amygdala Front Immunol. 2022 Oct 17;13:1005067.
- Talaei A, Farkhondeh T, Forouzanfar F. Fibroblast Growth Factor: Promising Target for Schizophrenia Curr Drug Targets. 2020;21(13):1344-1353.
- LaCrosse AL, Olive MF. Neuropeptide systems and schizophrenia CNS Neurol Disord Drug Targets. 2013 Aug;12(5):619-32.
- Berry T, Abohamza E, Moustafa AA. Treatment-resistant schizophrenia: focus on the transsulfuration pathway Rev Neurosci. 2020 Jan 28;31(2):219-232.
- Mizui T, Hattori K, Ishiwata S, Hidese S, Yoshida S, Kunugi H, Kojima M. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia J Psychiatr Res. 2019 Jun;113:190-198.
